Patients with a history of venous thromboembolism (VTE) are considered at very high risk for recurrence after lower limb arthroplasty (LLA). However, the chance of a new VTE episode after LLA has not been yet quantified. The aim of this study was to define the incidence of VTE recurrence following knee and hip arthroplasty. The case notes for all LLA patients treated at our hospital from 2009 to 2011 were reviewed. There were 5946 primary and revision LLA operations in total; 118 of these interventions were performed in 106 patients with a history of VTE. This group included 69 females and 37 males with a mean age of 69.9. Routine thromboprophylaxis for LLA patients included mechanical (footpumps & TED stockings) plus chemical prophylaxis using Aspirin 150 mg for 6 weeks. Patients with a VTE history had the same mechanical prophylaxis but received warfarin for 3 months. There were no fatal VTEs within 90 days of surgery. There were 5 episodes (4.2%) of VTE recurrence and specifically 4 PE and one DVT (femoral vein) at 4 months after the operation. Two of the PEs were asymptomatic, diagnosed on CTPA scans being requested for low O2 saturations on routine monitoring. In the group of patients without a VTE history there were 35 VTE episodes (0.6%), indicating a significantly lower rate of VTE (p=0.001) in comparison with the study group. Patients with a history of VTE had a 4.2% chance of having a further VTE. This is seven times greater than the rate among all other patients despite using more aggressive chemoprophylaxis.
Hip resurfacing preserves proximal femoral bone stock, optimises stress transfer to the proximal femur and offers inherent stability and optimal range of movement. The early results of metal–on-polyethylene resurfacing designs were poor and the resurfacing concept was largely abandoned. Modern metal-on-metal articulations enabled the introduction of a new generation of hip resurfacings with encouraging early results. In 1997 two of the authors developed a hip resurfacing system utilizing a metal-on-metal bearing. Our study reports on the clinical and radiological outcomes of the first 200 hips that were treated with the Durom hip resurfacing at an average follow up of 4.6 years (range 3.5–6). Between May 2001 and December 2003, 200 consecutive hip resurfacings were performed on 189 patients, using the Durom hybrid metal-on-metal system. The average age of the patients was 50 years (range 22.5 – 72.3) and 119 were male. Patients were seen at 6 weeks and at 3, 6 and 12 months and annually thereafter for clinical and radiological evaluation. Clinical results were evaluated using the Harris Hip Score. A subjective assessment of patient satisfaction was obtained and patient activity was assessed using the UCLA activity score. No patient was lost to follow up. There were no dislocations and no femoral neck fractures. One femoral component was revised due to aseptic loosening 3.9 years postoperatively. There was one late acute haematogenous infection that was successfully treated elsewhere by debridement and retention of the prosthesis. The mean Harris Hip Score improved significantly from 46.7 preoperatively to 94.4 postoperatively. The mean HHS constituents for pain, function and motion all were significantly improved from the preoperative values of 11.9, 25.7 and 4.2 to 41.8, 43.4 and 4.8 respectively following the resurfacing procedure. The mean UCLA activity score was 7.2 indicating a relatively active patient population and 179 hips were rated as excellent by the patients. No cup was considered radiographically loose. Extensive radiologic changes were observed around the femoral stem in 2.5% of the hips, with migration of the femoral component in one case and stem demarcation in 4 cases. All 5 patients maintained excellent function and had no hip pain. Pelvic osteolysis was observed in 2 cases. Neck remodelling changes were observed in 35 hips (17.5%). Kaplan-Mayer survivorship analysis demonstrated the rate of survival of the resurfacing components to be 99.5% (95% confidence interval 98.5 to 100) with revision for any reason as the endpoint. Early results with the Durom resurfacing system appear encouraging. Although these should be regarded with caution, modern metal-on-metal hip resurfacing potentially offers the ultimate bone preservation and restoration of function in appropriately selected young patients.
83 operatively treated patients with 85 fractures were followed-up. Anatomic reduction was achieved in 57 fractures, satisfactory in 18 and poor in 10 fractures. Functional outcome was excellent or good in 60 (72.3%) patients and fair and poor in 23 (27,7%).The complications were 3 wound infections, 4 cases of femoral head osteonecrosis, 3 cases of secondary loss of reduction and 5 cases of significant ectopic ossification.
We report on the early results of its use, mean follow-up 30 months, (range, 9–54 months). Between 1997 and 2001, 32 hip revisions using the Link MP reconstruction prosthesis were performed in 31 patients. There were 13 females and 18 males with a mean age of 65 years (range 35 – 82). The indication for the revision operation was aseptic loosening in twenty-one cases, septic loosening in six and periprosthetic fracture in five cases. Cancellous bone allografts were used in 25 patients. Patients with proven infection were treated by a two-stage procedure.